Multiple myeloma: an overview.
Multiple myeloma (MM) is a malignant hematologic disorder involving plasma cells. In MM, immunoglobulin is overproduced, and patients can develop skeletal, hematologic, renal, and/or neurologic complications. The exact etiology of MM is unknown. The treatment for MM includes chemotherapy, antiangiogenic medications, and, most recently, a proteasome inhibitor. Nursing care for patients with MM requires close monitoring for infections and anemia, pain control, and education about the disease and treatment options. Further understanding of the pathophysiology of MM may lead to newer treatment options for the disease.
Devenney
Brent
B
Fletcher Allen Hematology/Oncology Clinic, Burlington, VT, USA. Brent.Devenney@vtmednet.org
Erickson
Christy
C
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis
D000970:Antineoplastic Agents